These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26166795)

  • 1. The statement of the Polish Society of Allergology regarding necessary changes in therapeutic program of severe IgE-mediated allergic asthma with omalizumab.
    Bartuzi Z; Bodzenta-Łukaszyk A; Kuna P; Kupryś-Lipińska I; Niżankowska-Mogilnicka E; Samoliński B
    Pneumonol Alergol Pol; 2015; 83(4):335-8. PubMed ID: 26166795
    [No Abstract]   [Full Text] [Related]  

  • 2. IgE-mediated asthma: New revelations and future insights.
    Djukanovic R; Hanania N; Busse W; Price D
    Respir Med; 2016 Mar; 112():128-9. PubMed ID: 26577335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery and development of omalizumab for the treatment of asthma.
    Licari A; Marseglia G; Castagnoli R; Marseglia A; Ciprandi G
    Expert Opin Drug Discov; 2015; 10(9):1033-42. PubMed ID: 25979110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy.
    Odajima H; Ebisawa M; Nagakura T; Fujisawa T; Akasawa A; Ito K; Doi S; Yamaguchi K; Katsunuma T; Kurihara K; Kondo N; Sugai K; Nambu M; Hoshioka A; Yoshihara S; Sato N; Seko N; Nishima S
    Allergol Int; 2015 Oct; 64(4):364-70. PubMed ID: 26433533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing is everything: Targeting IgE to reduce asthma exacerbation risk.
    O'Byrne PM; Tworek D
    J Allergy Clin Immunol; 2015 Dec; 136(6):1486-1487. PubMed ID: 26654197
    [No Abstract]   [Full Text] [Related]  

  • 7. dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies.
    Palomares Ó; Sánchez-Ramón S; Dávila I; Prieto L; Pérez de Llano L; Lleonart M; Domingo C; Nieto A
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Omalizumab on Allergen-Specific IgE in Patients with Adult Asthma.
    Mizuma H; Tanaka A; Uchida Y; Fujiwara A; Manabe R; Furukawa H; Kuwahara N; Fukuda Y; Kimura T; Jinno M; Ohta S; Yamamoto M; Matsukura S; Adachi M; Sagara H
    Int Arch Allergy Immunol; 2015; 168(3):165-72. PubMed ID: 26790100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic Esophagitis Onset Despite Six Years' Treatment With Omalizumab in an Asthmatic Patient: No Protective Effect for Anti-IgE Therapy?
    Franceschini L; Macchiarelli R; Biviano I; Farsi A
    Am J Gastroenterol; 2021 Jul; 116(7):1560. PubMed ID: 33852452
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of anti-IgE therapy beyond allergic asthma.
    Stokes JR; Casale TB
    J Allergy Clin Immunol Pract; 2015; 3(2):162-6. PubMed ID: 25609342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical follow-up of omalizumab in routine treatment of allergic asthma monitored by CD-sens.
    Johansson SGO; Lilja G; Hallberg J; Nopp A
    Immun Inflamm Dis; 2018 Sep; 6(3):382-391. PubMed ID: 29737044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab therapy for children and adolescents with severe allergic asthma.
    Romano C
    Expert Rev Clin Immunol; 2015; 11(12):1309-19. PubMed ID: 26312385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between allergen immunotherapy and omalizumab for treating asthma.
    Braido F; Corsico A; Rogkakou A; Ronzoni V; Baiardini I; Canonica GW
    Expert Rev Respir Med; 2015 Apr; 9(2):129-34. PubMed ID: 25578528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review.
    Abraham I; Alhossan A; Lee CS; Kutbi H; MacDonald K
    Allergy; 2016 May; 71(5):593-610. PubMed ID: 26644231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma.
    Sposato B; Scalese M; Milanese M; Masieri S; Cavaliere C; Latorre M; Scichilone N; Matucci A; Vultaggio A; Ricci A; Cresti A; Paggiaro PL
    J Investig Allergol Clin Immunol; 2017; 27(6):388-391. PubMed ID: 29199967
    [No Abstract]   [Full Text] [Related]  

  • 18. Omalizumab in the Therapy of Pediatric Asthma.
    Poddighe D; Brambilla I; Licari A; Marseglia GL
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):103-109. PubMed ID: 29714140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FcεRI.
    Maggi L; Rossettini B; Montaini G; Matucci A; Vultaggio A; Mazzoni A; Palterer B; Parronchi P; Maggi E; Liotta F; Annunziato F; Cosmi L
    Eur J Immunol; 2018 Dec; 48(12):2005-2014. PubMed ID: 30252930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
    Kupryś-Lipińska I; Kuna P
    Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.